نتایج جستجو برای: refractory nhl lymphoma

تعداد نتایج: 155852  

Journal: :British journal of haematology 2016
Ross Pinkerton Mitchell S Cairo Finbarr E Cotter

The 5th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Varese, Italy, from 21-25 October 2015. This review represents a summary of the scientific sessions of this international symposium including childhood, adolescent and young adult (AYA) NHL in countries with limited socio-economic resources, AYA NHL, anaplastic large cell lymph...

Journal: :Blood 1985
R J Ford N M Kouttab C G Sahasrabuddhe F M Davis S R Mehta

The non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of human lymphoid tumors, primarily of B cell lineage, which appear to represent arrested stages in B lymphocyte differentiation. Control of cell proliferation is a fundamentally important but poorly understood area of study in these tumors. We have studied a representative group of B cell NHLs to assess their potential for growth fac...

Journal: :Hematological Oncology 2021

Allogeneic hematopoietic cell transplantation (alloHCT) used to play a defined role in the treatment of non-Hodgkin lymphoma (NHL). With advent modern targeted molecular therapies and immunotherapies, standards at least for B-cell have undergone significant changes, thereby questioning traditional alloHCT these diseases. This paper attempts describe current place perspectives rapidly evolving l...

Journal: :JPMA. The Journal of the Pakistan Medical Association 2000
S H Shah S Muzaffar S Pervez S H Hassan

OBJECTIVE To observe the frequency of histological subtypes of childhood non-Hodgkin's lymphoma and its immunohistochemical profile. SETTING All cases of non-Hodgkin's lymphoma diagnosed in children (< 15 years) in the section of histopathology at the Aga Khan University Hospital Karachi during the period of three years. METHODS These consecutive cases were evaluated on H&E stained sections...

Jayanta Das Mammen Chandy Saugata Sen Soumendranath Ray

Objective(s): The aim of this study is to evaluate the role of PET-CT in identification of different patterns of extranodal involvement in Hodgkin’s disease (HD) and Non-Hodgkin’s Lymphoma (NHL) and to enlist the common sites of extranodal involvement in each histological type and compare our results with the existing literature. Methods: In this retrospective study of 281 cases of lymphomas of...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
A Trebouet T Marchand R Lemal E Gyan F Broussais-Guillaumot Y Guillermin H Monjanel G Salles S Le Gouill P Godmer C Fruchart G Damaj P Feugier C Thieblemont M Maynadié A Monnereau X Troussard D Rossille T Lamy R Houot

BACKGROUND Lymphoma occurring in patients aged 90 or older is not uncommon, and its incidence is expected to increase over time. Management of these patients is difficult given their underlying fragility and the lack of information regarding this population. PATIENTS AND METHODS We retrospectively analyzed 234 patients diagnosed with lymphoma at the age of 90 years or older (90+) between 1990...

2006
Hyun Chang June-Won Cheong Jee-Sook Hahn

Autologous stem cell transplantation (ASCT) is commonly used in relapsed or refractory non-Hodgkin's lymphoma (NHL). Several trials report the role of ASCT for high risk patients. We evaluated the results and the prognostic factors influencing the therapeutic effects on the patients who were treated with high dose chemotherapy (HDC) and autologous peripheral stem cell transplantation. We analyz...

Journal: :Blood 2009
Hans-Peter Gerber May Kung-Sutherland Ivan Stone Carol Morris-Tilden Jamie Miyamoto Renee McCormick Stephen C Alley Nicole Okeley Brad Hayes Francisco J Hernandez-Ilizaliturri Charlotte F McDonagh Paul J Carter Dennis Benjamin Iqbal S Grewal

Despite major advances in the treatment of non-Hodgkin lymphoma (NHL), including the use of chemotherapeutic agents and the anti-CD20 antibody rituximab, the majority of patients eventually relapse, and salvage treatments with non-cross-resistant compounds are needed to further improve patient survival. Here, we evaluated the antitumor effects of the microtubule destabilizing agent monomethyl a...

Journal: :Haematologica 1994
P L Zinzani E Barbieri G Visani F Gherlinzoni F Perini S Neri M Bendandi I Ammendolia M Salvucci L Babini

BACKGROUND A fundamental principle in the therapeutic strategy for recurrent lymphomas is the employment of agents that are not part of the usual front line combination regimens. Ideally, the cytotoxic agents should lack complete cross resistance with those utilized up front. PATIENTS AND METHODS A three-drug combination of ifosfamide, epirubicin and etoposide (IEV) was used to treat 20 patie...

Journal: :Seminars in oncology nursing 2003
Arati V Rao Gamal Akabani David A Rizzieri

Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy in the United States with a rapidly increasing incidence. Most follicular NHL is indolent but incurable, whereas the more aggressive varieties do respond to therapy. Most patients with follicular NHL who transform to an aggressive NHL are very difficult to treat successfully. Treatment options have included chemotherapy, r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید